LRRC4 and ovarian cancer: Although EMT and MET are methods of tumor metastasis in ovarian cancer patients (39), our current study shows that LRRC4 acts as a suppressor gene to inhibit EOC cell collective invasion in an E-cadherin-dependent manner but not through EMT.